Asston Pharmaceuticals Reports H1 FY27 Financial Results
Asston Pharmaceuticals Ltd · Financial Result · 12 Nov 2026, 11:46 pm
Asston Pharmaceuticals Reports H1 FY27 Financial Results Asston Pharmaceuticals reported revenue from operations of ₹1,526.58 lakhs for the half-year ended 30th Sep'26, compared to ₹1,541.59 lakhs in the year-ago period ended 30th Sep'25 and ₹1,005.29 lakhs in H2 FY26. Net profit stood at ₹327.37 lakhs, down slightly from ₹338.21 lakhs YoY but up significantly from ₹48.30 lakhs in H2 FY26, with an unannualized basic and diluted EPS of ₹3.70. The company raised ₹2,771.58 lakhs via a preferential equity share allotment, expanding paid-up capital to ₹1,092.28 lakhs.
Original exchange filing (PDF)
More announcements from Asston Pharmaceuticals Ltd
- Outcome of the Board Meeting · 12 Nov 2026
- Asston Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2026 ,inter alia, to consider and approve the Unaudited Financial .... · 12 Nov 2026
- Change in registered office address · 13 Oct 2026
- Outcome of the Board held on 13th October, 2026. · 13 Oct 2026
- Asston Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/10/2026 ,inter alia, to consider and approve matters as attached · 06 Oct 2026
- Change in Management · 01 Oct 2026
- Appointment of Statutory Auditor of the Company · 01 Oct 2026
- Scrutinizer Report · 01 Oct 2026
